Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Am J Surg Pathol ; 44(10): 1322-1330, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32931680

RESUMEN

Trophoblastic differentiation (including choriocarcinoma) arising in urothelial carcinoma has been described in numerous case reports, but never in a single series. We present a series of these tumors, describing the morphologic spectrum, applying traditional and novel immunohistochemical stains, and characterizing clinical follow-up. We identified 16 cases, arising predominantly in the bladder (N=14), but also the ureter (N=1) and prostatic urethra (N=1). Six of our cases (38%) contained invasive urothelial carcinoma with admixed syncytiotrophoblasts, 8 cases (50%) consisted of invasive urothelial carcinoma with choriocarcinoma, 1 case (6%) showed urothelial carcinoma in situ with associated choriocarcinoma, and 1 case (6%) consisted of pure choriocarcinoma. Other subtypes of variant morphology were seen in 5 of our cases (31%) and included squamous, glandular, lipoid, chordoid/myxoid, and sarcomatoid features. Given the limited specificity of human chorionic gonadotropin immunohistochemistry, we also studied the expression of a novel specific trophoblastic marker, hydroxyl-δ-5-steroid dehydrogenase, as well as Sal-like protein 4. Human chorionic gonadotropin expression was seen in nearly all cases (93%) but was often not limited to the trophoblastic component, staining the urothelial component also in 85% of the cases. Expression of hydroxyl-δ-5-steroid dehydrogenase was more sensitive and more specific, staining 100% of the cases and limited to trophoblasts in all but 1 case. Sal-like protein 4 expression was variable, staining trophoblast in only 50% of cases and staining the urothelial carcinoma component in 43% of those positive cases. Most of our tumors presented at a high stage and were associated with poor clinical outcomes, with at least muscle-invasive disease (pT2) in 10 of the 14 bladder tumors (71%), periureteric fat invasion in the ureter tumor (pT3), distant metastases in 7 of 16 cases (44%) and death of disease in 3 of the 15 patients with follow-up (20%). Our study describes a series of urothelial carcinomas with trophoblastic differentiation, demonstrating the morphologic spectrum of this entity, its frequent association with other subtypes of variant morphology, its characteristic immunoprofile, and its aggressive clinical behavior.


Asunto(s)
Carcinoma de Células Transicionales/patología , Coriocarcinoma no Gestacional/patología , Trofoblastos/patología , Neoplasias Urológicas/patología , Adulto , Anciano , Anciano de 80 o más Años , Diferenciación Celular , Femenino , Humanos , Masculino , Persona de Mediana Edad , Urotelio/patología
2.
Mod Pathol ; 28(5): 612-30, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25412849

RESUMEN

The International Consultations on Urological Diseases are international consensus meetings, supported by the World Health Organization and the Union Internationale Contre le Cancer, which have occurred since 1981. Each consultation has the goal of convening experts to review data and provide evidence-based recommendations to improve practice. In 2012, the selected subject was bladder cancer, a disease which remains a major public health problem with little improvement in many years. The proceedings of the 2nd International Consultation on Bladder Cancer, which included a 'Pathology of Bladder Cancer Work Group,' have recently been published; herein, we provide a summary of developments and consensus relevant to the practicing pathologist. Although the published proceedings have tackled a comprehensive set of issues regarding the pathology of bladder cancer, this update summarizes the recommendations regarding selected issues for the practicing pathologist. These include guidelines for classification and grading of urothelial neoplasia, with particular emphasis on the approach to inverted lesions, the handling of incipient papillary lesions frequently seen during surveillance of bladder cancer patients, descriptions of newer variants, and terminology for urine cytology reporting.


Asunto(s)
Neoplasias de la Vejiga Urinaria , Humanos
3.
Eur Urol ; 63(2): 321-32, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23088996

RESUMEN

CONTEXT: Pathology standards for the diagnosis of bladder cancer (BCa) have recently evolved to better reflect patient diagnosis and clinical outcomes. OBJECTIVE: To update pathology reporting standards for BCa. EVIDENCE ACQUISITION: We searched the international medical literature and reviewed all articles that addressed BCa gross dissection, pathologic diagnosis, staging, and reporting as of June 6, 2012. We also reviewed the proceedings from the recent Second International Consultation on Bladder Cancer (Vienna, Austria). The literature selected for review focuses on evidence-based studies that address histopathologic factors in BCa, with emphasis placed on factors that influence patient diagnosis and clinical outcomes. EVIDENCE SYNTHESIS: We separated data into three main components for analysis based on the type of specimen obtained: (1) transurethral resection specimens, with an emphasis on pathologic staging, variants of urothelial carcinoma, angiolymphatic invasion, and relevant ancillary techniques such as immunohistochemistry in assessing these features; (2) cystectomy specimens, with an emphasis on pT0 disease, prostatic involvement by urothelial carcinoma and lymph node dissection and analysis; and (3) cytology correlates, with recommendations for the use of cytology paired with tissue-based sampling. Areas of controversy are described and recommendations based on existing guidelines are provided. The value of a multidisciplinary team is highlighted. CONCLUSIONS: Ongoing international collaborations amongst pathologists have led to emerging standards in the reporting and microscopic diagnosis of BCa specimens. Although some areas remain controversial, we present the most up-to-date data and guidelines relevant to neoplastic pathology of the urinary bladder.


Asunto(s)
Carcinoma de Células Transicionales/patología , Cistectomía/métodos , Neoplasias de la Vejiga Urinaria/patología , Carcinoma de Células Transicionales/cirugía , Humanos , Escisión del Ganglio Linfático/métodos , Estadificación de Neoplasias , Estándares de Referencia , Neoplasias de la Vejiga Urinaria/cirugía
4.
Am J Surg Pathol ; 37(2): 219-25, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23095506

RESUMEN

Currently there is no global agreement as to how extensively a radical prostatectomy specimen should be sectioned and histologically examined. We analyzed the ability of different methods of partial sampling in detecting positive margin (PM) and extraprostatic extension (EPE)-2 pathologic features of prostate cancer that are most easily missed by partial sampling of the prostate. Radical prostatectomy specimens from 617 patients treated with open radical prostatectomy between 1992 and 2011 were analyzed. Examination of the entirely submitted prostate detected only PM in 370 (60%), only EPE in 100 (16%), and both in 147 (24%) specimens. We determined whether these pathologic features would have been diagnosed had the examination of the specimen been limited only to alternate sections (method 1), alternate sections representing the posterior aspect of the gland in addition to one of the mid-anterior aspects (method 2), and every section representing the posterior aspect of the gland in addition to one of the mid-anterior aspects, supplemented by the remaining ipsilateral anterior sections if a sizeable tumor is seen (method 3). Methods 1 and 2 missed 13% and 21% of PMs and 28% and 47% of EPEs, respectively. Method 3 demonstrated better results missing only 5% of PMs and 7% of EPEs. Partial sampling techniques missed slightly more PMs and EPEs in patients with low-risk to intermediate-risk prostate cancer, although even in high-risk cases none of the methods detected all of the studied aggressive pathologic features.


Asunto(s)
Adenocarcinoma/patología , Prostatectomía , Neoplasias de la Próstata/patología , Adenocarcinoma/cirugía , Anciano , Humanos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Tamaño de los Órganos , Neoplasias de la Próstata/cirugía , Manejo de Especímenes/métodos , Adhesión del Tejido/métodos
5.
J Radiol Case Rep ; 7(11): 24-31, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24421927

RESUMEN

Silicone lymphadenopathy is a recognized complication of silicone gel implant rupture; the ipsilateral axillary lymph nodes are most commonly involved. We report imaging findings on a range of different imaging modalities and biopsy results in a case of biopsy-proven silicone lymphadenitis involving contralateral intramammary and axillary lymph nodes in a patient with an intact standard dual-lumen breast implant in the opposite reconstructed breast. This case demonstrates that in a patient with disrupted lymph drainage due to prior mastectomy and axillary node dissection for breast cancer treatment, silicone particles can migrate in a retrograde fashion via the ipsilateral internal mammary lymph nodes and reach not only the contralateral axilla but also the outer quadrants of the contralateral breast, even in the presence of an intact breast implant.


Asunto(s)
Implantes de Mama/efectos adversos , Linfadenitis/inducido químicamente , Geles de Silicona/efectos adversos , Axila , Mama , Neoplasias de la Mama/cirugía , Femenino , Humanos , Ganglios Linfáticos , Linfadenitis/diagnóstico , Imagen por Resonancia Magnética , Mastectomía Radical/efectos adversos , Persona de Mediana Edad
6.
Diagn Cytopathol ; 40(2): 138-40, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20891002

RESUMEN

The vaginal apex is the most common site of recurrence in patients with endometrial cancer. Although studies demonstrate that <1% of asymptomatic vaginal recurrences are detected by routine vaginal cytology alone, many practitioners still include it as part of the routine surveillance in these patients after hysterectomy. To further evaluate the effectiveness of vaginal cytology as a surveillance tool, we assessed the subsequent findings in patients reported to have benign and atypical glandular cells on vaginal cytology after hysterectomy performed for endometrial cancer.


Asunto(s)
Adenocarcinoma , Neoplasias Endometriales , Endometrio/patología , Recurrencia Local de Neoplasia , Adenocarcinoma/diagnóstico , Adenocarcinoma/patología , Biopsia , Neoplasias Endometriales/diagnóstico , Neoplasias Endometriales/patología , Endometrio/cirugía , Femenino , Estudios de Seguimiento , Humanos , Histerectomía , Recurrencia Local de Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/patología , Estadificación de Neoplasias , Prueba de Papanicolaou , Estudios Retrospectivos , Estados Unidos , Frotis Vaginal
11.
J Drugs Dermatol ; 3(2): 200-3, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15098980

RESUMEN

Hailey-Hailey disease, or familial benign chronic pemphigus, is a chronic disease without a known cure. Current therapeutic strategies attempt to suppress Hailey-Hailey outbreaks and allow the patient to live comfortably with this condition. We have found that applying topical tacrolimus 0.1% ointment (Protopic) twice a day to affected areas is an excellent way to control Hailey-Hailey disease. In addition to effectively controlling Hailey-Hailey outbreaks, tacrolimus is a relatively safe and noninvasive mode of treatment, without significant side effects. We recommend intermittent therapy with clobetasol propionate 0.05% foam (Olux Foam) for patients who break through suppressive therapy with tacrolimus a few times per year. In patients with frequent outbreaks of Hailey-Hailey disease despite suppressive therapy with tacrolimus, we recommend alternating the tacrolimus with clobetasol propionate 0.05% foam every 6 weeks.


Asunto(s)
Clobetasol/análogos & derivados , Clobetasol/uso terapéutico , Inmunosupresores/uso terapéutico , Pénfigo Familiar Benigno/tratamiento farmacológico , Tacrolimus/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pénfigo Familiar Benigno/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...